Cam Gallagher, President at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 55,536 shares at $26.40 ($1.5M) on 2023-05-31, disclosed to the SEC on 2023-05-31.
Scheduled sale ($1.5M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.21 | 18,526 | $486K | 33.3% |
| 2 | $26.21 | 18,526 | $486K | 33.3% |
| 3 | $26.40 | 9,242 | $244K | 16.7% |
| 4 | $26.40 | 9,242 | $244K | 16.7% |
| Total | $26.27 avg | 55,536 | $1.5M | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-02-14 | $475K | — | Filing → |